Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer.
Authors:
- 24 May 1994
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 91 (11) , 4673-4677
Abstract
After therapeutic hormone deprivation, prostate cancer cells often develop androgen-insensitive growth through mechanisms thus far undefined. Neuropeptides have been previously implicated as growth factors in some prostate cancers. Here, we demonstrate that androgen-sensitive LNCaP human prostate cancer cells produce and secrete neurotensin following androgen withdrawal. We show that while LNCaP cells express the neurotensin receptor, only androgen-deprived cells exhibit a growth response to exogenous neurotensin. We further demonstrate that androgen-stimulated cells may be refractory to exogenous neurotensin due to androgen induction of a metalloprotease active toward neurotensin. Thus, prostate cancer cells deprived of androgen develop an alternative autocrine growth mechanism involving neurotensin.Keywords
This publication has 36 references indexed in Scilit:
- Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptorFEBS Letters, 1993
- Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaPThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Neurotensin receptors in human meningiomasAnnals of Neurology, 1991
- Expression of Neurotensin Messenger RNA in a Human Carcinoid TumorAnnals of Surgery, 1991
- Characterization of neurotensin(6–13) from an hepatic fibrolamellar carcinomaPeptides, 1991
- Neurotensin may function as a regulatory peptide in small cell lung cancerPeptides, 1991
- Growth factors in human prostate cancer cells: Implications for an improved treatment of prostate cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Structure and functional expression of the cloned rat neurotensin receptorNeuron, 1990
- Differential expression of mRNA coding for heparin‐binding growth factor type 2 in human cellsJournal of Cellular Physiology, 1988
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985